Agarwal N, Rao D L, Murgeshan K, Verma U, Mittal S, Buckshee K, Chapeker T N
Int J Gynaecol Obstet. 1987 Apr;25(2):145-9. doi: 10.1016/0020-7292(87)90009-9.
Estrogen and progesterone receptors were estimated in a total of 25 ovarian neoplasms. None of the benign tumors showed steroid receptors. In malignant tumors serous tumors were more often receptor positive than the mucinous. Receptor levels were correlated with the staging of the disease, menstrual status and the resectability of the tumor. The response to chemotherapeutic drugs was better in patients with low estrogen and progesterone receptors as compared to those with high levels. The latter group showed a definite response to progesterone treatment in vitro. These are the group of patients who may benefit by combination of hormones and chemotherapeutic drugs.
